Studies show alarming rates of fatty liver disease in young Indians, prompting calls for lifestyle changes and early ...

Liver diseases are rising globally, claiming over 2 million lives annually, with viral hepatitis and alcoholic liver disease ...

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one ...

MASLD, previously called ‘fatty liver disease’, is a ticking timebomb, affecting 30 to 40 per cent of adults – most of whom ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

One in five individuals in India suffers from liver disease, according to renowned Epidemiologist Dr Naresh Purohit.

Medications and procedures to treat cirrhosis symptoms include ... can be fatal if it progresses to liver failure. There are two clinical stages of cirrhosis: compensated and decompensated ...

Non-Alcoholic Fatty Liver Disease (NAFLD) affects approximately 32.4% of the global population, making it the most common ...

Liver disease remains a silent threat. “The liver can withstand injury for years without producing symptoms,” said Dr ...

SUNRISE-PD evaluating the Company's anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson's disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one ...

Discover a study that ssessed the potential of urinary biomarkers to predict patient mortality in cirrhotic individuals.

Patients with cirrhosis are at an increased risk of bacterial infection (BI), which is the most common precondition for acute-on-chronic liver failure ...